2024 Q1 Form 10-Q Financial Statement

#000032019324000006 Filed on February 02, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4
Revenue $90.75B $119.6B
YoY Change 2.07%
Cost Of Revenue $48.48B $64.72B
YoY Change -3.15%
Gross Profit $42.27B $54.86B
YoY Change 8.99%
Gross Profit Margin 46.58% 45.87%
Selling, General & Admin $6.468B $6.786B
YoY Change 2.71%
% of Gross Profit 15.3% 12.37%
Research & Development $7.903B $7.696B
YoY Change -0.17%
% of Gross Profit 18.7% 14.03%
Depreciation & Amortization $2.836B $2.848B
YoY Change -2.33%
% of Gross Profit 6.71% 5.19%
Operating Expenses $14.37B $14.48B
YoY Change 1.16%
Operating Profit $27.90B $40.37B
YoY Change 12.1%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $158.0M -$50.00M
YoY Change -87.28%
Pretax Income $28.06B $40.32B
YoY Change 13.19%
Income Tax $4.422B $6.407B
% Of Pretax Income 15.76% 15.89%
Net Earnings $23.64B $33.92B
YoY Change 13.06%
Net Earnings / Revenue 26.04% 28.36%
Basic Earnings Per Share $1.53 $2.19
Diluted Earnings Per Share $1.53 $2.18
COMMON SHARES
Basic Shares Outstanding 15.44B shares 15.55B shares
Diluted Shares Outstanding 15.46B shares 15.58B shares

Balance Sheet

Concept 2024 Q1 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $67.15B $73.10B
YoY Change 42.34%
Cash & Equivalents $32.70B $40.76B
Short-Term Investments $34.46B $32.34B
Other Short-Term Assets $13.88B $13.98B
YoY Change -14.88%
Inventory $6.232B $6.511B
Prepaid Expenses
Receivables $21.84B $23.19B
Other Receivables $19.31B $26.91B
Total Short-Term Assets $128.4B $143.7B
YoY Change 11.58%
LONG-TERM ASSETS
Property, Plant & Equipment $43.55B $43.67B
YoY Change 1.66%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $95.19B $99.48B
YoY Change -12.81%
Other Assets $70.26B $66.68B
YoY Change 9.45%
Total Long-Term Assets $209.0B $209.8B
YoY Change -3.74%
TOTAL ASSETS
Total Short-Term Assets $128.4B $143.7B
Total Long-Term Assets $209.0B $209.8B
Total Assets $337.4B $353.5B
YoY Change 1.95%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $45.75B $58.15B
YoY Change 0.39%
Accrued Expenses
YoY Change
Deferred Revenue $8.012B $8.264B
YoY Change 3.4%
Short-Term Debt $1.997B $1.998B
YoY Change 14.63%
Long-Term Debt Due $10.76B $10.95B
YoY Change 12.46%
Total Short-Term Liabilities $123.8B $134.0B
YoY Change -2.41%
LONG-TERM LIABILITIES
Long-Term Debt $91.83B $95.09B
YoY Change -4.56%
Other Long-Term Liabilities $47.56B $50.35B
YoY Change -5.19%
Total Long-Term Liabilities $139.4B $145.4B
YoY Change -4.77%
TOTAL LIABILITIES
Total Short-Term Liabilities $123.8B $134.0B
Total Long-Term Liabilities $139.4B $145.4B
Total Liabilities $263.2B $279.4B
YoY Change -3.66%
SHAREHOLDERS EQUITY
Retained Earnings $4.339B $8.242B
YoY Change 154.38%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $74.19B $74.10B
YoY Change
Total Liabilities & Shareholders Equity $337.4B $353.5B
YoY Change 1.95%

Cashflow Statement

Concept 2024 Q1 2023 Q4
OPERATING ACTIVITIES
Net Income $23.64B $33.92B
YoY Change 13.06%
Depreciation, Depletion And Amortization $2.836B $2.848B
YoY Change -2.33%
Cash From Operating Activities $22.69B $39.90B
YoY Change 17.32%
INVESTING ACTIVITIES
Capital Expenditures $1.996B $2.392B
YoY Change -163.16%
Acquisitions
YoY Change
Other Investing Activities $1.686B $284.0M
YoY Change -87.87%
Cash From Investing Activities -$310.0M $1.927B
YoY Change -233.36%
FINANCING ACTIVITIES
Cash Dividend Paid $3.825B
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $0.00
YoY Change
Cash From Financing Activities -30.43B -$30.59B
YoY Change -14.0%
NET CHANGE
Cash From Operating Activities 22.69B $39.90B
Cash From Investing Activities -310.0M $1.927B
Cash From Financing Activities -30.43B -$30.59B
Net Change In Cash -8.053B $11.24B
YoY Change -474.19%
FREE CASH FLOW
Cash From Operating Activities $22.69B $39.90B
Capital Expenditures $1.996B $2.392B
Free Cash Flow $20.69B $37.50B
YoY Change -0.76%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2023Q4 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2023Q4 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2023Q4 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
CY2023Q4 us-gaap Hedged Asset Statement Of Financial Position Extensible Enumeration
HedgedAssetStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2023#MarketableSecuritiesCurrent http://fasb.org/us-gaap/2023#MarketableSecuritiesNoncurrent
CY2023Q3 us-gaap Hedged Asset Statement Of Financial Position Extensible Enumeration
HedgedAssetStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2023#MarketableSecuritiesCurrent http://fasb.org/us-gaap/2023#MarketableSecuritiesNoncurrent
CY2023Q4 us-gaap Hedged Liability Statement Of Financial Position Extensible Enumeration
HedgedLiabilityStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2023#LongTermDebtCurrent http://fasb.org/us-gaap/2023#LongTermDebtNoncurrent
CY2023Q3 us-gaap Hedged Liability Statement Of Financial Position Extensible Enumeration
HedgedLiabilityStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2023#LongTermDebtCurrent http://fasb.org/us-gaap/2023#LongTermDebtNoncurrent
CY2023Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
119575000000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
117154000000 usd
CY2023Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
64720000000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
66822000000 usd
CY2023Q4 us-gaap Gross Profit
GrossProfit
54855000000 usd
us-gaap Gross Profit
GrossProfit
50332000000 usd
CY2023Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7696000000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7709000000 usd
CY2023Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6786000000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6607000000 usd
CY2023Q4 us-gaap Operating Expenses
OperatingExpenses
14482000000 usd
us-gaap Operating Expenses
OperatingExpenses
14316000000 usd
CY2023Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
40373000000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
36016000000 usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
54611000000 usd
CY2023Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
58829000000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
43715000000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
66681000000 usd
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
64758000000 usd
CY2023Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
209822000000 usd
CY2023Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
209017000000 usd
CY2023Q4 us-gaap Assets
Assets
353514000000 usd
CY2023Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-50000000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-393000000 usd
CY2023Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
40323000000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
35623000000 usd
CY2023Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6407000000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5625000000 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
33916000000 usd
us-gaap Net Income Loss
NetIncomeLoss
29998000000 usd
CY2023Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.19
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.89
CY2023Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.18
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.88
CY2023Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15509763000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15892723000 shares
CY2023Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15576641000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15955718000 shares
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
33916000000 usd
us-gaap Net Income Loss
NetIncomeLoss
29998000000 usd
CY2023Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
308000000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-14000000 usd
CY2023Q4 aapl Other Comprehensive Income Loss Derivative Instrument Gain Lossbefore Reclassificationafter Tax
OtherComprehensiveIncomeLossDerivativeInstrumentGainLossbeforeReclassificationafterTax
-531000000 usd
aapl Other Comprehensive Income Loss Derivative Instrument Gain Lossbefore Reclassificationafter Tax
OtherComprehensiveIncomeLossDerivativeInstrumentGainLossbeforeReclassificationafterTax
-988000000 usd
CY2023Q4 aapl Other Comprehensive Income Loss Derivative Instrument Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossDerivativeInstrumentGainLossReclassificationAfterTax
823000000 usd
aapl Other Comprehensive Income Loss Derivative Instrument Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossDerivativeInstrumentGainLossReclassificationAfterTax
1766000000 usd
CY2023Q4 aapl Other Comprehensive Income Loss Derivative Instrument Gain Lossafter Reclassificationand Tax
OtherComprehensiveIncomeLossDerivativeInstrumentGainLossafterReclassificationandTax
-1354000000 usd
aapl Other Comprehensive Income Loss Derivative Instrument Gain Lossafter Reclassificationand Tax
OtherComprehensiveIncomeLossDerivativeInstrumentGainLossafterReclassificationandTax
-2754000000 usd
CY2023Q4 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
3045000000 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
900000000 usd
CY2023Q4 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
-75000000 usd
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
-65000000 usd
CY2023Q4 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
3120000000 usd
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
965000000 usd
CY2023Q4 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
2074000000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1803000000 usd
CY2023Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
35990000000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
28195000000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
40760000000 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
29965000000 usd
CY2023Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
32340000000 usd
CY2023Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
31590000000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
23194000000 usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
29508000000 usd
CY2023Q4 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
26908000000 usd
CY2023Q3 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
31477000000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
6511000000 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
6331000000 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
13979000000 usd
CY2023Q3 us-gaap Other Assets Current
OtherAssetsCurrent
14695000000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
143692000000 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
143566000000 usd
CY2023Q4 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
99475000000 usd
CY2023Q3 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
100544000000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
43666000000 usd
CY2023Q3 us-gaap Assets
Assets
352583000000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
58146000000 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
62611000000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
8264000000 usd
CY2023Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
8061000000 usd
CY2023Q4 us-gaap Commercial Paper
CommercialPaper
1998000000 usd
CY2023Q3 us-gaap Commercial Paper
CommercialPaper
5985000000 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
10954000000 usd
CY2023Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
9822000000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
133973000000 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
145308000000 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
95088000000 usd
CY2023Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
95281000000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
50353000000 usd
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
49848000000 usd
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
145441000000 usd
CY2023Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
145129000000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
279414000000 usd
CY2023Q3 us-gaap Liabilities
Liabilities
290437000000 usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50400000000 shares
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50400000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15460223000 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15460223000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15550061000 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15550061000 shares
CY2023Q4 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
75236000000 usd
CY2023Q3 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
73812000000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
8242000000 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-214000000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-9378000000 usd
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-11452000000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
74100000000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
62146000000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
353514000000 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
352583000000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
62146000000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
50672000000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
74100000000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
56727000000 usd
CY2023Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.24
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.23
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
30737000000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
24977000000 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
33916000000 usd
us-gaap Net Income Loss
NetIncomeLoss
29998000000 usd
CY2023Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2848000000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2916000000 usd
CY2023Q4 us-gaap Share Based Compensation
ShareBasedCompensation
2997000000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
2905000000 usd
CY2023Q4 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
989000000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
317000000 usd
CY2023Q4 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-6555000000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-4275000000 usd
CY2023Q4 us-gaap Debt Securities Available For Sale Restricted
DebtSecuritiesAvailableForSaleRestricted
13900000000 usd
CY2023Q4 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-4569000000 usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-2320000000 usd
CY2023Q4 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
137000000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1807000000 usd
CY2023Q4 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1457000000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
4099000000 usd
CY2023Q4 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-4542000000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-6075000000 usd
CY2023Q4 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-3865000000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
3889000000 usd
CY2023Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
39895000000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
34005000000 usd
CY2023Q4 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
9780000000 usd
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
5153000000 usd
CY2023Q4 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
13046000000 usd
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
7127000000 usd
CY2023Q4 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
1337000000 usd
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
509000000 usd
CY2023Q4 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2392000000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3787000000 usd
CY2023Q4 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
284000000 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
141000000 usd
CY2023Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1927000000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1445000000 usd
CY2023Q4 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2591000000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2316000000 usd
CY2023Q4 us-gaap Payments Of Dividends
PaymentsOfDividends
3825000000 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
3768000000 usd
CY2023Q4 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
20139000000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
19475000000 usd
CY2023Q4 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1401000000 usd
CY2023Q4 us-gaap Proceeds From Repayments Of Commercial Paper
ProceedsFromRepaymentsOfCommercialPaper
-3984000000 usd
us-gaap Proceeds From Repayments Of Commercial Paper
ProceedsFromRepaymentsOfCommercialPaper
-8214000000 usd
CY2023Q4 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-46000000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-389000000 usd
CY2023Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-30585000000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-35563000000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
11237000000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-3003000000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
41974000000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
21974000000 usd
CY2023Q4 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
7255000000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
828000000 usd
CY2023Q3 us-gaap Debt Securities Available For Sale Restricted
DebtSecuritiesAvailableForSaleRestricted
13800000000 usd
CY2023Q4 us-gaap Fiscal Period
FiscalPeriod
<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company’s fiscal year is the 52- or 53-week period that ends on the last Saturday of September. An additional week is included in the first fiscal quarter every five or six years to realign the Company’s fiscal quarters with calendar quarters, which occurred in the first fiscal quarter of 2023. The Company’s fiscal years 2024 and 2023 span 52 and 53 weeks, respectively. Unless otherwise stated, references to particular years, quarters, months and periods refer to the Company’s fiscal years ended in September and the associated quarters, months and periods of those fiscal years.</span></div>
CY2023Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
119575000000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
117154000000 usd
CY2023Q4 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
3500000000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
3400000000 usd
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
12500000000 usd
CY2023Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
12100000000 usd
CY2023Q4 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.66
CY2023Q4 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.26
CY2023Q4 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.07
CY2023Q4 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.01
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
33916000000 usd
us-gaap Net Income Loss
NetIncomeLoss
29998000000 usd
CY2023Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15509763000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15892723000 shares
CY2023Q4 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
66878000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
62995000 shares
CY2023Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15576641000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15955718000 shares
CY2023Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.19
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.89
CY2023Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.18
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.88
CY2023Q4 aapl Cash Cash Equivalents And Marketable Securities Cost
CashCashEquivalentsAndMarketableSecuritiesCost
180248000000 usd
CY2023Q4 aapl Cash Equivalents And Marketable Securities Accumulated Gross Unrealized Gain Before Tax
CashEquivalentsAndMarketableSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
266000000 usd
CY2023Q4 aapl Cash Equivalents And Marketable Securities Accumulated Gross Unrealized Loss Before Tax
CashEquivalentsAndMarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
7939000000 usd
CY2023Q4 aapl Cash Cash Equivalents And Marketable Securities
CashCashEquivalentsAndMarketableSecurities
172575000000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
40760000000 usd
CY2023Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
32340000000 usd
CY2023Q4 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
99475000000 usd
CY2023Q3 aapl Cash Cash Equivalents And Marketable Securities Cost
CashCashEquivalentsAndMarketableSecuritiesCost
173752000000 usd
CY2023Q3 aapl Cash Equivalents And Marketable Securities Accumulated Gross Unrealized Gain Before Tax
CashEquivalentsAndMarketableSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
30000000 usd
CY2023Q3 aapl Cash Equivalents And Marketable Securities Accumulated Gross Unrealized Loss Before Tax
CashEquivalentsAndMarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
11683000000 usd
CY2023Q3 aapl Cash Cash Equivalents And Marketable Securities
CashCashEquivalentsAndMarketableSecurities
162099000000 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
29965000000 usd
CY2023Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
31590000000 usd
CY2023Q3 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
100544000000 usd
CY2023Q4 us-gaap Available For Sale Securities Debt Maturities Rolling Year Two Through Five Fair Value
AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue
72994000000 usd
CY2023Q4 us-gaap Available For Sale Securities Debt Maturities Rolling Year Six Through Ten Fair Value
AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue
9368000000 usd
CY2023Q4 us-gaap Available For Sale Securities Debt Maturities Rolling After Year Ten Fair Value
AvailableForSaleSecuritiesDebtMaturitiesRollingAfterYearTenFairValue
17113000000 usd
CY2023Q4 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
99475000000 usd
CY2023Q4 us-gaap Hedged Asset Fair Value Hedge
HedgedAssetFairValueHedge
15102000000 usd
CY2023Q3 us-gaap Hedged Asset Fair Value Hedge
HedgedAssetFairValueHedge
14433000000 usd
CY2023Q4 us-gaap Hedged Liability Fair Value Hedge
HedgedLiabilityFairValueHedge
18661000000 usd
CY2023Q3 us-gaap Hedged Liability Fair Value Hedge
HedgedLiabilityFairValueHedge
18247000000 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
116176000000 usd
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
114599000000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
72510000000 usd
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
70884000000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
43666000000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
43715000000 usd
CY2023Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2997000000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2905000000 usd
CY2023Q4 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
1235000000 usd
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
1178000000 usd
CY2023Q4 us-gaap Proceeds From Repayments Of Short Term Debt Maturing In Three Months Or Less
ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess
-3984000000 usd
us-gaap Proceeds From Repayments Of Short Term Debt Maturing In Three Months Or Less
ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess
-5569000000 usd
CY2023Q4 us-gaap Repayments Of Short Term Debt Maturing In More Than Three Months
RepaymentsOfShortTermDebtMaturingInMoreThanThreeMonths
0 usd
us-gaap Repayments Of Short Term Debt Maturing In More Than Three Months
RepaymentsOfShortTermDebtMaturingInMoreThanThreeMonths
2645000000 usd
CY2023Q4 us-gaap Proceeds From Repayments Of Commercial Paper
ProceedsFromRepaymentsOfCommercialPaper
-3984000000 usd
us-gaap Proceeds From Repayments Of Commercial Paper
ProceedsFromRepaymentsOfCommercialPaper
-8214000000 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
106000000000 usd
CY2023Q3 us-gaap Long Term Debt
LongTermDebt
105100000000 usd
CY2023Q4 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
118000000 shares
CY2023Q4 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
20500000000 usd
CY2023Q4 us-gaap Loss Contingency Disclosures
LossContingencyDisclosures
Contingencies<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company is subject to various legal proceedings and claims that have arisen in the ordinary course of business and that have not been fully resolved. The outcome of litigation is inherently uncertain. In the opinion of management, there was not at least a reasonable possibility the Company may have incurred a material loss, or a material loss greater than a recorded accrual, concerning loss contingencies for asserted legal and other claims.</span></div>
CY2023Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
40373000000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
36016000000 usd
CY2023Q4 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000320193-24-000006-index-headers.html Edgar Link pending
0000320193-24-000006-index.html Edgar Link pending
0000320193-24-000006.txt Edgar Link pending
0000320193-24-000006-xbrl.zip Edgar Link pending
a10-qexhibit31112302023.htm Edgar Link pending
a10-qexhibit31212302023.htm Edgar Link pending
a10-qexhibit32112302023.htm Edgar Link pending
aapl-20231230.htm Edgar Link pending
aapl-20231230.xsd Edgar Link pending
aapl-20231230_g1.jpg Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
aapl-20231230_cal.xml Edgar Link unprocessable
aapl-20231230_def.xml Edgar Link unprocessable
aapl-20231230_lab.xml Edgar Link unprocessable
aapl-20231230_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
aapl-20231230_htm.xml Edgar Link completed
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending